<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-039908</identifier>
<setSpec>0210-5705</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Clinical heterogeneity and distinct outcomes in hepatic epithelioid</dc:title>
<dc:description xml:lang="en">Epithelioid hemangioendothelioma is an infrequent mesenchymal tumor of unknown etiology and variable clinical symptoms. It usually affects black, middle-aged women. The most frequent symptoms are right hypochondrium pain, abdominal discomfort and constitutional syndrome with progressive liver damage. Diagnosis is difficult and detailed pathological analysis is required. Controlled clinical studies are lacking and there are no factors that predict the clinical course or serve as a guide to the most effective treatment. We report 3 cases with distinct clinical course ranging from clinical stability to dissemination and death. Treatment differed in the three patients</dc:description>
<dc:creator>Matilla, A</dc:creator>
<dc:creator>Álvarez, E</dc:creator>
<dc:creator>Núñez, O</dc:creator>
<dc:creator>Clemente, G</dc:creator>
<dc:creator>Bañares, R</dc:creator>
<dc:creator>Ponferrada, A</dc:creator>
<dc:creator>Salcedo, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El hemangioendotelioma epitelioide es un tumor infrecuente de naturaleza mesenquimal, etiología desconocida y clínica muy variable. Suele afectar a mujeres de raza blanca de edad media. Los síntomas más frecuentes son dolor en el hipocondrio derecho, malestar abdominal y síndrome constitucional con deterioro progresivo de la función hepática. El diagnóstico resulta difícil y es necesario un estudio anatomopatológico minucioso. No hay estudios clínicos controlados y tampoco hay variables predictivas del curso clínico que orienten hacia un tratamiento más eficaz de este tumor. Se exponen 3 casos que presentaron distinto curso clínico, desde la estabilización clínica hasta la diseminación y el fallecimiento, y que recibieron diversos tratamientos</dc:description>
<dc:source>Gastroenterol Hepatol;28(6): 321-325, jun.-jul. 2005. ilus</dc:source>
<dc:identifier>ibc-039908</dc:identifier>
<dc:title xml:lang="es">Heterogeneidad clínica y evolutiva del hemangioendotelioma epitelioide hepático</dc:title>
<dc:subject>^d31421^s22064</dc:subject>
<dc:subject>^d8069</dc:subject>
<dc:subject>^d12080^s22053</dc:subject>
<dc:subject>^d6664^s22012</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d33344^s22012</dc:subject>
<dc:subject>^d8287^s22016</dc:subject>
<dc:subject>^d1884^s22064</dc:subject>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d31421^s22053</dc:subject>
<dc:subject>^d22261</dc:subject>
<dc:subject>^d8287^s22053</dc:subject>
<dc:subject>^d31421^s22058</dc:subject>
<dc:subject>^d29936</dc:subject>
<dc:subject>^d8287^s22058</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29770</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d8352^s22058</dc:subject>
<dc:subject>^d29476</dc:subject>
<dc:subject>^d14995</dc:subject>
<dc:subject>^d8352^s22064</dc:subject>
<dc:subject>^d31474</dc:subject>
<dc:subject>^d31421^s22016</dc:subject>
<dc:subject>^d37554</dc:subject>
<dc:subject>^d32285</dc:subject>
<dc:type>article</dc:type>
<dc:date>200507</dc:date>
</metadata>
</record>
</ibecs-document>
